Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Maze Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MAZE.
You can purchase shares of Maze Therapeutics (NASDAQ:MAZE) through any online brokerage.
Other companies in Maze Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
Maze Therapeutics has a consensus price target of $25.67.
The stock price for Maze Therapeutics (NASDAQ: MAZE) is $11.14 last updated March 21, 2025 at 4:33 PM EDT.
There are no upcoming dividends for Maze Therapeutics.
Maze Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Maze Therapeutics.
Maze Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.